What does Adaptive Biotechnologies Corporation do?
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical…
What is Adaptive Biotechnologies Corporation's P/E and P/B ratio?
Adaptive Biotechnologies Corporation has a P/E ratio of -59.5 and a P/B ratio of 27.26.
What is Adaptive Biotechnologies Corporation's debt-to-equity ratio?
Adaptive Biotechnologies Corporation has a debt-to-equity ratio of 2.72.
How much does Adaptive Biotechnologies Corporation owe compared with what it owns?
Adaptive Biotechnologies Corporation owes $0.76 for every $1 it owns (balance sheet Jun 2026), which is moderate.
What is Adaptive Biotechnologies Corporation's Positivity rank?
Adaptive Biotechnologies Corporation is ranked #6,195 of 6,774 companies globally and #3,525 of 4,000 in United States on PositoAI, with a Positivity Score of 3,667.
Does Adaptive Biotechnologies Corporation have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Adaptive Biotechnologies Corporation.
Where can I read the latest news about Adaptive Biotechnologies Corporation?
Recent headlines about Adaptive Biotechnologies Corporation from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Adaptive Biotechnologies Corporation have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Adaptive Biotechnologies Corporation's current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.